This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5n8v
From Proteopedia
(Difference between revisions)
m (Protected "5n8v" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Targeting the PEX14-PEX5 interaction by small molecules provides novel therapeutic routes to treat trypanosomiases.== | |
| - | + | <StructureSection load='5n8v' size='340' side='right' caption='[[5n8v]], [[Resolution|resolution]] 1.55Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[5n8v]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5N8V OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5N8V FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BME:BETA-MERCAPTOETHANOL'>BME</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=KZZ:1-(2-AZANYLETHYL)-5-[(4-METHOXYNAPHTHALEN-1-YL)METHYL]-~{N}-(NAPHTHALEN-1-YLMETHYL)-6,7-DIHYDRO-4~{H}-PYRAZOLO[4,3-C]PYRIDINE-3-CARBOXAMIDE'>KZZ</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | |
| - | [[ | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5l8a|5l8a]], [[5l87|5l87]]</td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5n8v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5n8v OCA], [http://pdbe.org/5n8v PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5n8v RCSB], [http://www.ebi.ac.uk/pdbsum/5n8v PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5n8v ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
[[Category: Dawidowski, M]] | [[Category: Dawidowski, M]] | ||
| - | [[Category: Popowicz, G.M]] | ||
[[Category: Emmanouilidis, L]] | [[Category: Emmanouilidis, L]] | ||
| + | [[Category: Popowicz, G M]] | ||
[[Category: Sattler, M]] | [[Category: Sattler, M]] | ||
| + | [[Category: Glycosome]] | ||
| + | [[Category: Inhibitor]] | ||
| + | [[Category: Protein-protein interaction inhibitor]] | ||
| + | [[Category: Signaling protein]] | ||
| + | [[Category: Structure-based drug discovery]] | ||
| + | [[Category: Trypanosomiasis]] | ||
Revision as of 21:21, 15 March 2017
Targeting the PEX14-PEX5 interaction by small molecules provides novel therapeutic routes to treat trypanosomiases.
| |||||||||||
